Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.21 billion. The enterprise value is $1.21 billion.
Market Cap | 1.21B |
Enterprise Value | 1.21B |
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 46.84 million shares outstanding. The number of shares has increased by 2.31% in one year.
Current Share Class | 46.84M |
Shares Outstanding | 46.84M |
Shares Change (YoY) | +2.31% |
Shares Change (QoQ) | -0.55% |
Owned by Insiders (%) | 1.51% |
Owned by Institutions (%) | 98.86% |
Float | 46.12M |
Valuation Ratios
The trailing PE ratio is 56.92 and the forward PE ratio is 25.44. Omnicell's PEG ratio is 43.76.
PE Ratio | 56.92 |
Forward PE | 25.44 |
PS Ratio | 1.05 |
Forward PS | 1.03 |
PB Ratio | 0.96 |
P/TBV Ratio | 4.30 |
P/FCF Ratio | 9.66 |
P/OCF Ratio | 7.38 |
PEG Ratio | 43.76 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.33, with an EV/FCF ratio of 9.65.
EV / Earnings | 56.96 |
EV / Sales | 1.06 |
EV / EBITDA | 17.33 |
EV / EBIT | 96.11 |
EV / FCF | 9.65 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.31.
Current Ratio | 1.38 |
Quick Ratio | 1.07 |
Debt / Equity | 0.31 |
Debt / EBITDA | 4.84 |
Debt / FCF | 3.09 |
Interest Coverage | 2.39 |
Financial Efficiency
Return on equity (ROE) is 1.73% and return on invested capital (ROIC) is 0.46%.
Return on Equity (ROE) | 1.73% |
Return on Assets (ROA) | 0.35% |
Return on Invested Capital (ROIC) | 0.46% |
Return on Capital Employed (ROCE) | 0.81% |
Revenue Per Employee | $309,470 |
Profits Per Employee | $5,772 |
Employee Count | 3,670 |
Asset Turnover | 0.51 |
Inventory Turnover | 6.62 |
Taxes
In the past 12 months, Omnicell has paid $12.71 million in taxes.
Income Tax | 12.71M |
Effective Tax Rate | 37.50% |
Stock Price Statistics
The stock price has decreased by -13.95% in the last 52 weeks. The beta is 0.78, so Omnicell's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | -13.95% |
50-Day Moving Average | 32.67 |
200-Day Moving Average | 40.46 |
Relative Strength Index (RSI) | 28.65 |
Average Volume (20 Days) | 749,755 |
Short Selling Information
The latest short interest is 2.45 million, so 5.24% of the outstanding shares have been sold short.
Short Interest | 2.45M |
Short Previous Month | 2.40M |
Short % of Shares Out | 5.24% |
Short % of Float | 5.32% |
Short Ratio (days to cover) | 4.14 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.14 billion and earned $21.18 million in profits. Earnings per share was $0.45.
Revenue | 1.14B |
Gross Profit | 491.12M |
Operating Income | 12.56M |
Pretax Income | -20.77M |
Net Income | 21.18M |
EBITDA | 69.63M |
EBIT | 12.56M |
Earnings Per Share (EPS) | $0.45 |
Balance Sheet
The company has $386.83 million in cash and $385.83 million in debt, giving a net cash position of $999,000 or $0.02 per share.
Cash & Cash Equivalents | 386.83M |
Total Debt | 385.83M |
Net Cash | 999,000 |
Net Cash Per Share | $0.02 |
Equity (Book Value) | 1.26B |
Book Value Per Share | 26.84 |
Working Capital | 232.14M |
Cash Flow
In the last 12 months, operating cash flow was $163.69 million and capital expenditures -$38.68 million, giving a free cash flow of $125.02 million.
Operating Cash Flow | 163.69M |
Capital Expenditures | -38.68M |
Free Cash Flow | 125.02M |
FCF Per Share | $2.67 |
Margins
Gross margin is 43.24%, with operating and profit margins of 1.11% and 1.87%.
Gross Margin | 43.24% |
Operating Margin | 1.11% |
Pretax Margin | 2.98% |
Profit Margin | 1.87% |
EBITDA Margin | 6.13% |
EBIT Margin | 1.11% |
FCF Margin | 11.01% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.31% |
Shareholder Yield | n/a |
Earnings Yield | 1.75% |
FCF Yield | 10.35% |
Analyst Forecast
The average price target for Omnicell is $45.83, which is 77.77% higher than the current price. The consensus rating is "Buy".
Price Target | $45.83 |
Price Target Difference | 77.77% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 15.20% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.09 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.09 |
Piotroski F-Score | 7 |